Friday, October 30, 2009

Agencies partner to launch social media service for pharma companies

Pin It Now!
Cara Wood of DMNews.com writes, Extrovertic and Virilion announced a joint venture on October 28, called EV Healthcare, to help healthcare companies implement digital and social media marketing campaigns. The service, based in New York, has just begun marketing to prospective clients, saidPfizer veteran Dorothy Wetzel, co-founder and executive marketer at Extrovertic.

“When there's a lot of change there's a lot of opportunity,” Wetzel said. ”Consumers are more often getting healthcare information from digital and social channels. Traditional direct-to-consumer campaigns are under fire, the most innocuous campaigns are attacked because consumers are more skeptical of pharma advertising. Healthcare companies need compelling creative strategy and true consumer dialogue.”

What do you think of the joint venture into the pharma and social media sphere? We'd like to hear how you think this evolves -- will we see more partnerships to come?

Thursday, October 29, 2009

Archived Webinar: Shifting Media, Shifting Minds – Optimize Online Engagement

Pin It Now!
If you missed your chance to view yesterday's live web seminar presented by Bill Drummy, the CEO of Heartbeat Digital, here's your chance to view it at your own leisure! Take some time to view the hour long webinar below. Enjoy!

https://www1.gotomeeting.com/register/367946673

Tuesday, October 27, 2009

Complimentary Webinar: Shifting Media, Shifting Minds – Optimize Online Engagement

Pin It Now!
Join us for a Webinar on Wednesday, October 28
2-3PM EST

Space is limited.
Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/367946673
Mention Priority Code: P1506LinkedInBLOG


About the web seminar:
The days of one-way brand communication (i.e. advertising) are over. Engagement, utility and brand evangelism are the secrets to success in the user-controlled world of Facebook and Twitter. See how some major brands have exploited the new digital realities. Heartbeat Digital CEO Bill Drummy presents real-world examples showing how Bayer, J&J, Novo Nordisk, and UCB are racing ahead into the digital future.

What you will learn:
• The dramatic change in consumer media consumption patterns
• Who’s really using social networking and what are they doing
• The real data behind Facebook & Twitter
• The “reason for being” of various social networking environments and how to harness their unique capabilities
• Real-world examples of effective social networking campaigns

About the speaker:
Bill Drummy is CEO of Heartbeat Digital, an independent interactive marketing and software company he founded in 1998. Heartbeat is headquartered in New York, with offices in Brussels, Geneva, Paris and London. Named one of pharma’s “100 Most Inspiring People,” by PharmaVoice, Bill has provided strategic guidance at the highest levels for Amgen, GSK, sanofi-aventis, UCB and many other leading pharma and biotech companies. Bill’s reputation as a strategic thinker is well-known; he’s regularly published on industry issues and has been a featured speaker at major industry conferences, including DTC National ePharma Summit, and the Conference on Marketing.

Thursday, October 22, 2009

Chris Anderson, Editor in Chief of Wired magazine will be at ePharma 2010!

Pin It Now!
Chris Anderson, Editor in Chief of Wired magazine, will be a keynote presenter
at the ePharma Summit in February 2010

Are you interested in How Emerging Technologies Will Impact Consumer Behavior & Preferences? If the answer is yes, be sure to join us on the morning of Wednesday, February 10th at 8:15 at the ePharma Summit 2010, where Chris Anderson will discuss the long tail of the pharmaceutical industry and the inevitable shift towards the “mini buster” and personalized medicine. Understand how the economics of abundance and the evolving digital landscape will forever influence the way you sell and market pharmaceutical products.

Wednesday, October 21, 2009

Widget Wonderland at FDA-Who Knew?

Pin It Now!
Angie Drakulich of PharmTech News writes today that the FDA will hold its public meeting to discuss the use of social media tools in marketing pharmaceutical drug products. The last time the agency held a meeting to discuss these types of items was in 1996 when the Internet’s popularity was growing by leaps and bounds.

While the agency is doing its best to figure out how to regulate online marketing—which comes with a whole new set of timing variables—it’s also working to keep up with technology on its own website. For example, last week, FDA posted a new widget that highlights fraudulent H1N1 swine-flu prevention and treatment products.

Drakulich also writes, FDA actually has a few widgets available. A peanut product recall widget lists all products pulled from the market for peanut contamination. A MedWatch widget highlights industry news including adverse events and product safety information. A food safety widget links to food safety programs at the agency as well as information on foodborne illnesses, allergies, and more. Some more simple FDA widgets are noted on the agency website here.

Widget Wonderland at FDA-Who Knew?

Thursday, October 15, 2009

Dr. David Blumenthal's view on medical records

Pin It Now!
The New York Times recently had a piece where Dr. David Blumenthal, an adviser for President Obama on digitizing health records, spoke about what the current situation is for transition to digitized medical records and what the benefits will be when US doctors fully move over to the system. This includes patients being able to better manage their care and doctors and hospitals performing at higher levels. Read the full interview here.

Wednesday, October 14, 2009

Free Webinar Tomorrow: Overcoming the Challenges of Government Pricing, Compliance Reporting and Medicaid Rebate Processing

Pin It Now!

October 15, 2009
2-3PM EST

Space is limited.
Reserve your Webinar seat now at: https://www1.gotomeeting.com/register/286708561

Priority code: P1458W1BLOG/TWITTER


About the web seminar:
All pharmaceutical product manufacturers who sell to various agencies of the federal government and/or who participate in Medicaid, 340B, Medicare or other public sector reimbursement programs face significant requirements and challenges with respect to their government-mandated pricing calculations and compliance reporting processes. Huge penalties and fines can be levied for miscalculating or incorrectly applying the various government price types to government-contracted sales and/or for compliance reporting mistakes.

The Seminar will address the complexities and challenges associated with automating Government Pricing and Medicaid Rebate system(s) as well as the pros and cons of using a packaged-software approach versus a custom-development approach. An overview of a leading-edge enterprise solution, developed as a fully-integrated component of the SAP® Enterprise Resource Planning (ERP) System, will be presented, accompanied by a live software demonstration and followed by a Question & Answer discussion of the issues.

What you will learn:
• An appreciation of the historical and legal background and context for the government-mandated price calculations and compliance reporting requirements;
• An understanding of the various price types that must be calculated, used in sales transaction processing and reported under each corresponding government program;
• Why automating and managing these processes using a packaged solution, based upon a fully-integrated enterprise architecture, is the lowest risk and lowest Total Cost of Ownership (TCO) approach


After registering you will receive a confirmation email containing information about joining the Webinar.

System Requirements
PC-based attendees
Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista
Macintosh®-based attendees
Required: Mac OS® X 10.4 (Tiger®) or newer

Friday, October 9, 2009

Complimentary Web Seminar: Shifting Media, Shifting Minds

Pin It Now!
Title: Shifting Media, Shifting Minds
Date: Wednesday, October 28, 2009
Time: 2:00 PM - 3:00 PM EDT

Register here: https://www1.gotomeeting.com/register/367946673
Mention Priority code: P1506LinkedInBlog

About the web seminar:
The days of one-way brand communication (i.e. advertising) are over. Engagement, utility and brand evangelism are the secrets to success in the user-controlled world of Facebook and Twitter. See how some major brands have exploited the new digital realities. Heartbeat Digital CEO Bill Drummy presents real-world examples showing how Bayer, J&J, Novo Nordisk, and UCB are racing ahead into the digital future.

What you will learn:
• The dramatic change in consumer media consumption patterns
• Who’s really using social networking and what are they doing
• The real data behind Facebook & Twitter
• The “reason for being” of various social networking environments and how to harness their unique capabilities
• Real-world examples of effective social networking campaigns

About the speaker:
Bill Drummy is CEO of Heartbeat Digital, an independent interactive marketing and software company he founded in 1998. Heartbeat is headquartered in New York, with offices in Brussels, Geneva, Paris and London. Named one of pharma’s “100 Most Inspiring People,” by PharmaVoice, Bill has provided strategic guidance at the highest levels for Amgen, GSK, sanofi-aventis, UCB and many other leading pharma and biotech companies. Bill’s reputation as a strategic thinker is well-known; he’s regularly published on industry issues and has been a featured speaker at major industry conferences, including DTC National ePharma Summit, and the Conference on Marketing.

Thursday, October 8, 2009

Pharma Drops Search Advertising After FDA Warning

Pin It Now!
Fearing any further warnings or issues from the FDA, Pharma companies have dropped search advertising on search engines. AdAge reports that according to a study from web metrics measurement firm ComScore, paid search ads by pharmaceutical companies dropped a whopping 84% between March 26 of this year and the end of June. Pharma companies that believed they were in compliance with the unwritten "one-click rule" -- taking the consumer from the ad to a site that offered fair balance and the risk information by clicking on the ad -- immediately began pulling paid search ads, according to the study.

For more information about the changes in search engines from Pharma companies, please click here.

Pharma Drops Search Advertising After FDA Warning

Tuesday, October 6, 2009

New Multi-Marketing Channel Strategies for Pharma

Pin It Now!
The future of Pharma marketing lies in using new marketing channels such as social media intertwined with traditional marketing practices to create a multi-channel marketing mix. However, online brand promotion through social media is more effective for targeting patients than physicians, indicating direct marketing tactics to physicians through social media should be limited. Datamonitor’s report, New Multi-Marketing Channel Strategies provides an overview of the reasons behind the need for new marketing channels and explores the different channel mixes used to reach the pharma industry’s diverse customer base (focusing on patients and doctors). The report also examines the use of online technology, especially social media and uses in-depth case study analysis to examine the pros and cons of each method, while providing actionable recommendations on the appropriateness of the respective targeted audiences.


Friday, October 2, 2009

FDA To Hold Hearings On Social-Media Use By Drug Makers

Pin It Now!
Mediapost.com reports that pharmaceutical companies in a quandary about what they can and cannot do on Web 2.0 are welcoming news that the Food and Drug Administration will hold a two-day public hearing on the issue Nov. 12-13 in Washington, Rich Thomaselli reports. Ad agencies that specialize in health-care marketing say the hearings, and any resulting guidelines, will be helpful for the industry which, by and large, has avoided participating in social media for fear of an FDA warning letter.

With the new guidelines set by the FDA, will we see participation in social media increase by pharmaceutical companies? We'd like to hear your thoughts.

FDA To Hold Hearings On Social-Media Use By Drug Makers

Thursday, October 1, 2009

Microsoft releases My Heatlh Info

Pin It Now!
According to Channel Web, Microsoft has released it's version of online medical records, My Health Info, to the public. It's beta version is now online for individuals to begin managing their healthcare information, from high blood pressure to coordinating the medication they're using. It also has an area for vaccines records as well as lab results. Read about the new release here.

What audience do you think is most likely to take advantage of online health care records? And is the younger generation going to jump on the personal health records bandwagon? They've propelled many online services such as MySpace and Facebook, but will they be likely to share their private medical data with Microsoft?